MedImmune, Amgen and GlaxoSmithKline are all set to exit Adheron in a deal that could potentially rise to $580m if all milestones are met.

The Roche-backed oncology treatment developer floated below its range in an IPO in which Pfizer and Bristol-Myers Squibb both acquired shares.

SAP-backed Sapphire Ventures will exit the ticketing technology platform through an acquisition that will expand music recommendation service Pandora's product offering.

The China-based local services and group buying companies had raised a combined $2.6bn from backers including Alibaba, Tencent, Xiaomi, Fosun and Wanda Group.

Cloud application technology provider Intalio had raised about $60m from investors including Sapphire Ventures, formerly part of enterprise software company SAP, and VMware.

The Samsung-backed flash storage technology provider will float at the middle of the IPO's range, and could potentially raise up to $489m.

Vodafone and MTI will exit cloud communications technology company Jibe, which had raised $9.1m, as Google agrees to buy it for an undisclosed sum.

The Pfizer, Baxter and Celgene-backed oncology company will raise $43.7m from an initial public offering where the share price was effectively halved in the space of two weeks.

The Pfizer, Baxter and Celgene-backed oncology company will raise $43.7m from an initial public offering where the share price was effectively halved in the space of two weeks.